Keros Therapeutics, Inc. (KROS)

Keros Therapeutics Revenue

Keros Therapeutics had revenue of $14.26M in the quarter ending September 30, 2025, with 3,575.77% growth. This brings the company's revenue in the last twelve months to $246.72M, up 37,798.31% year-over-year. In the year 2024, Keros Therapeutics had annual revenue of $3.55M with 2,250.99% growth.

• Revenue (ttm): $246.72M
• Revenue Growth: +37,798.31%
• P/S Ratio: 2.88
• Revenue / Employee: $3,008,756
• Employees: 82
• Market Cap: 534.07M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	3.55M	3.40M	2,250.99%
Dec 31, 2023	151.00K	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	20.10M	-	-
Dec 31, 2020	-	-	-